Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 618

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 618
---
 employed “named executive officers” whose compensation was disclosed in the Definitive Proxy Statement on Schedule 14A filed by Kineta on April 26, 2024. This compensation is referred to as “golden parachute” compensation by the applicable SEC disclosure rules, and in this section such term is used to describe the merger-related compensation payable to Craig Philips, Kineta’s President and Keith Baker, Kineta’s Chief Financial Officer, who are entitled to such types of compensation. As previously disclosed, Shawn Iadonato, Kineta’s other “named executive officer,” is no longer employed by Kineta and is not entitled to any compensation in connection with the Mergers that could be considered “golden parachute” compensation, so he is excluded from the discussion below. As previously disclosed, Kineta entered into a separation and release agreement with Dr. Iadonato effective March 1, 2024, pursuant to which Dr. Iadonato received a payment equal to 80 hours of accrued but unused paid time off and two weeks’ worth of wages, which in aggregate equaled $38,462, in exchange for Dr. Iadonato’s execution of a release in favor of the Company of any and all claims relating to his employment with the Company. 400

The description of the employment agreement between Kineta and Mr. Philips, dated September 28, 2022 (the “Philips Employment Agreement”) and employment agreement between Kineta and Mr. Baker, dated September 20, 2022 (the “Baker Employment Agreement”) set forth in the section above titled “Executive Compensation” are incorporated herein by reference. The amounts set forth in the table below, which represent an estimate of Messrs. Philips’ and Baker’s respective golden parachute compensation as of [●], 2025, calculated in accordance with the SEC’s rules on disclosing golden parachute compensation, assume the following:

| • |     | consummation of the Mergers constitutes a change in control for purpose of each of the Philips Employment Agreement and the Baker Employment Agreement; |

| • |     | the change in control is consummated on [●], 2025, the latest practicable date prior to the filing of this Form S-4; |

| • |     | that each of Messrs. Philips’ and Baker’s employment is terminated without “cause” or with “good reason” immediately following the Mergers; and |

| • |     | no named executive officer receives any additional equity grants